Antiangiogenic tyrosine kinase inhibitors: Occurrence and risk factors of hemoptysis in refractory thyroid cancer

Livia Lamartina, S. Ippolito, M. Danis, F. Bidault, I. Borget, A. Berdelou, A. Al Ghuzlan, D. Hartl, P. Blanchard, M. Terroir, D. Deandreis, M. Schlumberger, E. Baudin, S. Leboulleux

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

Background: Antiangiogenic tyrosine kinase inhibitors (TKIs) are the mainstay of advanced thyroid cancer (TC) treatment. Concern is rising about TKI-related toxicity. Objective: To determine the incidence and to investigate the risk factors of hemoptysis in TC patients during TKI treatment. Methods: We analyzed consecutive TC patients treated with TKI in our center between 2005 and 2013 and performed an independent review of computed tomography scan images for airway invasion assessment. Occurrence of grade 1-2 or grade 3-5 hemoptysis according to Common Terminology Criteria for Adverse Events version 4.03 and risk factors for hemoptysis were investigated. Results: A total of 140 patients (89 males; median age, 52 y) with medullary (56%), differentiated (33%), and poorly differentiated (11%) TC were enrolled. Thyroidectomy-neck dissection was performed in 123 patients and neck/mediastinum external-beam radiotherapy in 41 (32% with therapeutic purpose and 68% with adjuvant purpose). Patients received from 1 to 4 lines of TKI (median 1). Median follow-up was 24 months. Airway invasion was found in 65 (46%) cases. Hemoptysis occurred in 9 patients: grade 1-2 in 7 cases (5%) and grade 3-5 in 2 (1.4%) cases (fatal in 1). Hemoptysis was associated with presence of airway invasion (P <.04), poorly differentiated pathology (P <.03), history of therapeutic external-beam radiotherapy (P <.003), and thyroidectomy without neck dissection (P <.02). Conclusion: Airway invasion, poorly differentiated pathology, therapeutic external-beam radiotherapy, and thyroidectomy without neck dissection are associated with and increased risk of hemoptysis in TC patients during antiangiogenic TKI treatment. Further research is needed to confirm this data and to sort out interactions between these risk factors. A careful assessment of airway invasion is mandatory before TKI introduction.

Original languageEnglish
Pages (from-to)2733-2741
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number7
DOIs
Publication statusPublished - 1 Jul 2016
Externally publishedYes

Cite this